by Jordana Choucair | Jun 13, 2022 | Life Sciences
An Associated Press review of federal records found that U.S. regulators did not inspect the three biggest baby formula manufacturers in 2020, as the onset of the pandemic disrupted the typical annual cadence of site visits. Following a two-year lapse in inspections...
by Jordana Choucair | Jun 10, 2022 | Life Sciences
The House passed a bill to reauthorize drug industry fees to help fund the Food and Drug Administration (FDA) for the next five years. The package includes measures to overhaul the agency’s accelerated approval process, increase diversity in clinical trials and...
by Jordana Choucair | Jun 9, 2022 | Life Sciences
The White House announced that it is shifting some of its COVID-19 funding to invest more in vaccines and the antiviral treatment Paxlovid. The administration will divert a total of $10 billion from testing and personal protective equipment – $5 billion will go...
by Jordana Choucair | Jun 9, 2022 | Life Sciences
Pharmacies and states have already ordered millions of COVID-19 vaccine doses for small children in anticipation of federal authorization next week. Of the 5 million doses initially available, about 1.45 million Pfizer doses and 850,000 Moderna shots have been...
by Jordana Choucair | Jun 8, 2022 | Life Sciences
The Federal Trade Commission (FTC) announced that it will investigate the business practices of pharmacy benefit managers (PBMs) and how they influence drug prices and the pharmacy business. The FTC unanimously voted Tuesday to require the six biggest PBMs — CVS...
by Jordana Choucair | Jun 8, 2022 | Life Sciences
New research published in JAMA found that nearly half of all drugs launched in the last two years initially cost above $150,000 a year. From 2008 to 2021, launch prices for new drugs increased by 20 percent per year. In 2020-2021 alone, prices rose 11 percent per year...
Recent Comments